Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Recruiting

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

NCT06174987

Conditions
Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
Locations
  • Miami Cancer Institute Miami, Florida, United States
  • Duke University - Trent Center Durham, North Carolina, United States
  • Flinders Medical Center Bedford Park, Australia
  • Monash Medical Center Melbourne, Australia
View all 28 locations
View Trial Details
Recruiting

A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors

NCT05461768

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Dongguan People's Hospital Dongguan, Guangdong, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangdong, Guangzhou, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Recruiting

A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor

NCT05194982

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Renmin Hospital of Wuhan University Wuhan, Hubei, China
View Trial Details
Recruiting

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

NCT05808634

Conditions
Advanced Adenocarcinoma, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • UC Irvine Irvine, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Recruiting

RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis

NCT06397313

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Policlinico Sant'Orsola-Malpighi Bologna, Italy
  • Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia Brescia, Italy
  • Azienda Ospedaliero Universitaria Policlinico "G. Rodolico - San Marco" Catania, Italy
  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. Meldola, Italy
View all 18 locations
View Trial Details
Recruiting

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

NCT07070479

Conditions
Carcinoma, Disease Attributes, Head and Neck Neoplasms, +18 more
Locations
  • Cancer Center of Guangzhou Medical University Guangzhou, Guangdong, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Zhongshan People's Hospital Zhongshan, Guangdong, China
View Trial Details

Related conditions